Division of Pediatric Critical Care Medicine, University of Washington School of Medicine, Seattle Children's Hospital, Seattle, WA, USA.
Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA.
Pediatr Transplant. 2021 May;25(3):e13913. doi: 10.1111/petr.13913. Epub 2020 Nov 11.
Inclusion of BMI as criterion in the determination of heart transplant candidacy in children is a clinical and ethical challenge. Childhood obesity is increasing and children with heart disease are not spared. Currently, many adult heart transplant centers consider class II obesity and higher (BMI > 35 kg/m ) to be a relative contraindication for transplantation due to risk of poor outcome after transplant. No national guidelines exist regarding consideration of BMI in pediatric heart transplant and outcomes data are limited. This leaves decisions about transplant candidacy in obese pediatric patients to individual institutions or on a case-by-case basis, allowing for bias and inequity.
We review (a) the prevalence of childhood obesity, including among heart transplant candidates, (b) the lack of existing BMI guidelines, and (c) relevant literature on BMI and pediatric heart transplant outcomes. We discuss the ethical considerations of using obesity as a criterion using the principles of utility, justice, and respect for persons.
Existing transplant outcomes data do not show that obese children have different or poor enough outcomes compared to non-obese children to warrant exclusion. Moreover, obesity in the United States is unequally distributed by race and socioeconomic status. Children already suffering from health disparities are therefore doubly penalized if obesity denies them access to life-saving transplant.
Insufficient data exist to support using any BMI cutoff as an absolute contraindication for heart transplant in children. Attention should be paid to health equity issues when considering excluding a patient for transplant based on obesity.
将 BMI 纳入儿童心脏移植候选者的标准是一个临床和伦理挑战。儿童肥胖症的发病率正在上升,患有心脏病的儿童也未能幸免。目前,许多成人心脏移植中心认为二级肥胖症及以上(BMI>35kg/m )是移植的相对禁忌证,因为移植后预后不良的风险较高。关于 BMI 在儿科心脏移植中的考虑,目前尚无国家指南,并且数据有限。这使得肥胖儿科患者的移植候选资格决策取决于各个机构或具体情况,从而存在偏见和不公平。
我们回顾了(a)儿童肥胖症的流行情况,包括心脏移植候选者中的肥胖症;(b)缺乏现有的 BMI 指南;以及(c)BMI 与儿科心脏移植结局相关的文献。我们讨论了使用肥胖症作为标准的伦理考虑,使用了效用、公正和尊重个人的原则。
现有的移植结局数据并未表明肥胖儿童的结局与非肥胖儿童不同或足够差,足以排除他们。此外,美国的肥胖症在种族和社会经济地位方面分布不均。如果肥胖症使他们无法获得拯救生命的移植,那么已经遭受健康差距的儿童将受到双重惩罚。
目前的数据不足以支持将任何 BMI 截止值用作儿童心脏移植的绝对禁忌证。在考虑因肥胖而排除患者进行移植时,应注意公平问题。